Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Clifton O, Bingham Iii"'
Autor:
Joel M. Kremer, Clifton O. Bingham III, Laura C. Cappelli, Jeffrey D. Greenberg, Ann M. Madsen, Jamie Geier, Jose L. Rivas, Alina M. Onofrei, Christine J. Barr, Dimitrios A. Pappas, Heather J. Litman, Kimberly J. Dandreo, Andrea B. Shapiro, Carol A. Connell, Arthur Kavanaugh
Publikováno v:
ACR Open Rheumatology, Vol 3, Iss 3, Pp 173-184 (2021)
Objective Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). We compared 5‐year adverse event (AE) incidence rates (IRs) between patients initiating tofacitinib and those initiating new biological disease
Externí odkaz:
https://doaj.org/article/619fc16b87424da49083d4b79c261367
Publikováno v:
ACR Open Rheumatology, Vol 1, Iss 5, Pp 303-307 (2019)
Objective Immune checkpoint inhibitors (ICI) are transforming the field of oncology, leading to tumor regression in multiple advanced cancers. With this case series, we review the ultrasound imaging findings in a series of patients with ICI‐induced
Externí odkaz:
https://doaj.org/article/e2d0199af45d48e7af126aa7b25305d2
Autor:
Clifton O. Bingham III, Anna Kristina Gutierrez, Alessandra Butanis, Vivian P. Bykerk, Jeffrey R. Curtis, Amye Leong, Anne Lyddiatt, W. Benjamin Nowell, Ana Maria Orbai, Susan J. Bartlett
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 3, Iss 1, Pp 1-9 (2019)
Abstract Background Fatigue is prevalent and impactful in rheumatoid arthritis (RA). There is no standardized measure for its assessment nor data concerning the performance of PROMIS-Fatigue short forms (SFs) in people with RA. We evaluated the const
Externí odkaz:
https://doaj.org/article/457876113a5e40858888e43cb1655da4
Autor:
Dana DiRenzo, Didem Saygin, Ingrid de Groot, Clifton O. Bingham III, Ingrid E. Lundberg, Merrilee Needham, Jin Kyun Park, Malin Regardt, Catherine Sarver, Yeong Wook Song, Lara Maxwell, Dorcas Beaton, Marianne de Visser, Lisa Christopher-Stine, Christopher A. Mecoli, Helene Alexanderson
Publikováno v:
Seminars in arthritis and rheumatism, 58:152111. W.B. Saunders Ltd
Objective: Pain interference, fatigue, and impaired physical function are common features of idiopathic inflammatory myopathies (IIM). The objective of this study was to evaluate the construct validity and test-retest reliability of the Patient Repor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea003e311b4e09dd1e7463b08656a0a5
https://pubmed.ncbi.nlm.nih.gov/36410180
https://pubmed.ncbi.nlm.nih.gov/36410180
Autor:
Manuel, Ramos-Casals, Alexandre, Maria, María E, Suárez-Almazor, Olivier, Lambotte, Benjamin A, Fisher, Gabriela, Hernández-Molina, Philippe, Guilpain, Xerxes, Pundole, Alejandra, Flores-Chávez, Chiara, Baldini, Clifton O, Bingham Iii, Pilar, Brito-Zerón, Jacques-Eric, Gottenberg, Marie, Kostine, Timothy R D, Radstake, Thierry, Schaeverbeke, Hendrik, Schulze-Koops, Leonard, Calabrese, Munther A, Khamashta, Xavier, Mariette
Publikováno v:
Clinical and experimental rheumatology
Clinical and experimental rheumatology, Clinical and Experimental Rheumatology Sas, 2019, 37 Suppl 118 (3), pp.114-122
Clinical and experimental rheumatology, Clinical and Experimental Rheumatology Sas, 2019, 37 Suppl 118 (3), pp.114-122
International audience; To analyse the worldwide occurrence of sicca/Sjögren's (SS) syndrome associated with the use of immune checkpoint inhibitors (ICI) in patients with cancer.METHODS:The ImmunoCancer International Registry (ICIR) is a Big Data-S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c64906b7a4f5e876c4e0cab113fdc2ab
http://hdl.handle.net/11568/1063470
http://hdl.handle.net/11568/1063470
